HIV therapeutic possibilities of gold compounds
- 3 February 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in BioMetals
- Vol. 23 (2), 185-196
- https://doi.org/10.1007/s10534-010-9293-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Inhibition of HIV Fusion with Multivalent Gold NanoparticlesJournal of the American Chemical Society, 2008
- Gold(III) compounds as anticancer agents: Relevance of gold–protein interactions for their mechanism of actionJournal of Inorganic Biochemistry, 2008
- Nanotechnological applications in medicineCurrent Opinion in Biotechnology, 2007
- The chemistry of cyano complexes of gold(I) with emphasis on the ligand scrambling reactionsCoordination Chemistry Reviews, 2004
- Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details. See http://www.rsc.org/suppdata/cc/b3/b303294a/Chemical Communications, 2003
- A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activityProceedings of the National Academy of Sciences of the United States of America, 1999
- The Connection Domain Is Implicated in Metalloporphyrin Binding and Inhibition of HIV Reverse TranscriptasePublished by Elsevier BV ,1999
- Gold drugs: Mechanism of action and toxicityGold Bulletin, 1996
- PRODUCTION OF INTERLEUKIN-6 BY MONOCYTES ISOLATED FROM RHEUMATOID ARTHRITIS PATIENTS RECEIVING SECOND-LINE DRUG THERAPYRheumatology, 1994
- Effects of coordinated gold compounds on in vitro and in situ DNA replicationBiochemical Pharmacology, 1985